AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22902096
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Simvastatin and Bezafibrate)
Trial: 19953579
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg epinephrine plus normal saline (group 1; n = 38)
Trial: 19953579
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg epinephrine plus 3% saline (group 2; n = 39)
Trial: 19953579
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg salbutamol plus normal saline (group 3; n = 36)
Trial: 19953579
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg salbutamol plus 3% saline (group 4; n = 36)
Trial: 12585098
Drug: Conventional method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional method with corticosteroids and/or immunosuppressant
Trial: 1300803
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy and preoperative radiotherapy
Trial: 3895037
Drug: Isoniazid therapy
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid therapy (up to 1200 mg/d)
Trial: 23512235
Drug: Intra-space injection
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-space injection of Twin mix
Trial: 23512235
Drug: Per-oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Per-oral dexamethasone
Trial: 19858140
Drug: L-FMC after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-FMC after isometric exercise
Trial: 19858140
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of L-FMC and FMD
Trial: 17645472
Drug: peg‐IFN 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peg‐IFN 1.0 mug/kg/week + ribavirin 10.6 mg/kg/day
Trial: 17645472
Drug: peg‐IFN 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peg‐IFN 1.5 microg/kg/week + ribavirin 10.6 mg/kg/day
Trial: 15980699
Drug: VaxGen VAX004
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VaxGen VAX004 study (HIV vaccine efficacy trial)
Trial: 2841251
Drug: Enalapril (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20-40 mg)
Trial: 2841251
Drug: Captopril (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50-100 mg)
Trial: 16284232
Drug: Eprosartan 600
RxNorm normalized name: eprosartan 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan 600 mg daily
Trial: 10902987
Drug: Energy supplement
RxNorm normalized name: Nutritional Supplement Oral Bar [PROTEIN FORTIFIED ENERGY SUPPLEMENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy supplement (1171 kJ + 12 mg iron)
Trial: 10902987
Drug: Micronutrient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient supplement (209 kJ + 12 mg iron)
Trial: 9166392
Drug: HRT +
RxNorm normalized name: Hormone Replacement Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT + Vit D (2 mg estradiol valerate and 1 mg cyproterone acetate + 300 IU/day vitamin D3)
Trial: 9166392
Drug: Placebo (calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (calcium lactate; 93 mg Ca2+/day)
Trial: 8335785
Drug: Sealants applied
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sealants applied with a bonding agent on wet enamel
Trial: 8335785
Drug: Sealants applied
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sealants applied without a bonding agent on wet enamel
Trial: 26573925
Drug: liraglutide (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: liraglutide (0.6 mg for 2 days, 1.2 mg for 2 days, followed by 1.8 mg for 3 days)
Trial: 22628062
Drug: Escitalopram formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram formulation by Grupo Tecnimede
Trial: 22628062
Drug: European reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: European reference formulation
Trial: 16171242
Drug: Pregabalin 150
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 150 mg t.i.d.
Trial: 16171242
Drug: Alprazolam 1
RxNorm normalized name: alprazolam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 1 mg t.i.d.
Trial: 10227337
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 220 microg twice daily
Trial: 1650315
Drug: Sulindac, 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac, 300 mg/day
Trial: 7280947
Drug: No parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No parenteral antibiotics
Trial: 30616441
Drug: Stay Balanced
RxNorm normalized name: benzalkonium chloride Topical Foam [Stay Clean]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stay Balanced program (progressive balance training, group sessions twice a week for 10 weeks)
Trial: 28359259
Drug: Sedative group
RxNorm normalized name: MedActive Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedative group (Propofol and sufentanil)
Trial: 28359259
Drug: Routine group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine group (without sedative)
Trial: 18379759
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oxycodone
Trial: 10634646
Drug: G-CSF +
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF + HDMP
Trial: 8729209
Drug: Rifabutin (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifabutin (450 or 600 mg/d)
Trial: 1420648
Drug: Naloxone infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone infusion (10 mg plus 7 mg/hr for a total of 94 mg)
Trial: 3841228
Drug: Pirenzepine 40
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 40 mg
Trial: 21358504
Drug: 1.8 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g/d N-3 (omega-3 fatty acids)
Trial: 17008194
Drug: Naltrexone (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (25 mg daily for 3 days prior to quit date, then 50 mg/day for 8 weeks)
Trial: 14676759
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg penicillin G potassium troches (Cankercillin)
Trial: 10708160
Drug: Flumazenil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.5 mg bolus injection)
Trial: 9089853
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural block with 0.6 mL/kg of 0.25% bupivacaine with 1:200,000 epinephrine before incision (n = 28)
Trial: 9089853
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural block with 0.6 mL/kg of 0.25% bupivacaine with 1:200,000 epinephrine after surgery (n = 23)
Trial: 24021667
Drug: Facial‐Oral Tract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Facial‐Oral Tract Therapy
Trial: 20080201
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 microg twice-daily
Trial: 16793625
Drug: Delisheng injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delisheng injection combined with IMRT
Trial: 15115135
Drug: Both vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both vaccines concomitantly
Trial: 1595104
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 75 mg dipyridamole and 330 mg acetylsalicylic acid three times a day
Trial: 6142906
Drug: Triazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.5 mg) with ethanol (60 ml vodka + 60 ml water)
Trial: 6142906
Drug: Triazolam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.5 mg) with water (100 to 200 ml)
Trial: 28670938
Drug: Aspirin 75
RxNorm normalized name: aspirin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 75 mg daily for four weeks
Trial: 27038034
Drug: High-dose glucocorticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose glucocorticosteroid treatment
Trial: 27038034
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose glucocorticosteroid treatment
Trial: 27038034
Drug: Another type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Another type of high-dose glucocorticosteroid treatment
Trial: 25381721
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg ETV once daily; 2 g RGT three times daily
Trial: 25381721
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg ETV once daily; 2 g RGT dummy agent three times daily
Trial: 16040370
Drug: Single drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drug alcohol intervention
Trial: 11989836
Drug: Wheat grass
RxNorm normalized name: Wheat grass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat grass juice (100 cc daily for 1 month)
Trial: 10084293
Drug: Intravenous L-carnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L-carnitine (5 mg/kg for 15 patients and 25 mg/kg for 5 patients) with intravenous iron saccharate (20 mg/HD session) for four months.
Trial: 10084293
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with intravenous iron saccharate (20 mg/HD session) for four months.
Trial: 10084293
Drug: Intravenous L-carnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous L-carnitine with iron supplementation.
Trial: 2127377
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin spray (0.4 mg)
Trial: 2127377
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin tablet (0.4 mg)
Trial: 26372387
Drug: Darunavir/ritonavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/ritonavir monotherapy (DRV/r) 800/100 mg once daily
Trial: 26372387
Drug: Darunavir/ritonavir with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/ritonavir with two nucleoside analogues (triple therapy)
Trial: 24231879
Drug: Top-dose phentermine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Top-dose phentermine plus topiramate-extended release (15/92 mg)
Trial: 21932023
Drug: Immediate placement
RxNorm normalized name: IR DIP 10 1 % Iodine Replacement Teat Dip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate placement of OsseoSpeed implants in fresh extraction sockets
Trial: 21932023
Drug: Immediate placement
RxNorm normalized name: IR DIP 10 1 % Iodine Replacement Teat Dip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate placement of OsseoSpeed implants in healed edentulous ridges
Trial: 17530036
Drug: Cefditoren pivoxil
RxNorm normalized name: Cefditoren Pivoxil
DrugBank: Cefditoren (DB01066)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefditoren pivoxil 200 mg single dose
Trial: 17530036
Drug: Cefditoren pivoxil
RxNorm normalized name: Cefditoren Pivoxil
DrugBank: Cefditoren (DB01066)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefditoren pivoxil 400 mg single dose
Trial: 17530036
Drug: Cefditoren pivoxil
RxNorm normalized name: Cefditoren Pivoxil
DrugBank: Cefditoren (DB01066)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefditoren pivoxil 400 mg b.i.d. for 10 days
Trial: 17530036
Drug: Cefditoren pivoxil
RxNorm normalized name: Cefditoren Pivoxil
DrugBank: Cefditoren (DB01066)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefditoren pivoxil 400 mg t.i.d. for 10 days
Trial: 17530036
Drug: Cefditoren pivoxil
RxNorm normalized name: Cefditoren Pivoxil
DrugBank: Cefditoren (DB01066)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefditoren pivoxil 400 mg b.i.d. and t.i.d.
Trial: 17530036
Drug: Cefditoren pivoxil
RxNorm normalized name: Cefditoren Pivoxil
DrugBank: Cefditoren (DB01066)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefditoren pivoxil 400 mg t.i.d.
Trial: 11704172
Drug: ORTHO EVRA/EVRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORTHO EVRA/EVRA (transdermal contraceptive system delivering norelgestromin 150 microg and ethinyl estradiol 20 microg daily)
Trial: 9600581
Drug: Buspirone (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (3 x 5 mg)
Trial: 9600581
Drug: Lorazepam (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam (3 x 1 mg)
Trial: 31506077
Drug: 12-week dietary
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week dietary intervention promoting weekly consumption of 2.5 cups of cruciferous vegetables and 3.5 cups of green leafy vegetables
Trial: 23130655
Drug: SRP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP plus 1% metformin gel
Trial: 15084614
Drug: ATRA and
RxNorm normalized name: ATRA
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ATRA and chemotherapy (CT) for maintenance
Trial: 11437888
Drug: Aspirin (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (320 mg administered three times at 4-hour intervals)
Trial: 7935224
Drug: GTN (0.1%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTN (0.1%, solved in NaCl; dose 2.8 +/- 0.5 mg/h)
Trial: 7935224
Drug: ISDN (0.1%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISDN (0.1%, solved in NaCl; dose 4.8 +/- 0.8 mg/h)
Trial: 7935224
Drug: Placebo (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.9% NaCl solution, 3 ml/h)
Trial: 3428378
Drug: Four-site intradermal
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-site intradermal (i.d.) PCEC regimen
Trial: 3428378
Drug: Eight-site intradermal
RxNorm normalized name: OC Eight
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eight-site intradermal (i.d.) PCEC regimen
Trial: 3428378
Drug: Three-site intramuscular
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-site intramuscular (i.m.) PCEC regimen
Trial: 3428378
Drug: Subcutaneous regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous regimen using suckling mouse brain (SMB) rabies vaccine
Trial: 3428378
Drug: Human rabies
RxNorm normalized name: Human rabies virus immune globulin
DrugBank: Rabies immune globulin, human (DB11603)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human rabies immune globulin therapy
Trial: 26867075
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral treatment for reducing hostility (12-week program)
Trial: 24726294
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 150 mg/kg IV over 20 hours
Trial: 24726294
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of N-acetylcysteine (NAC) and infliximab (5 mg/kg IV as a single 2-hour administration)
Trial: 20459775
Drug: mTOR-inhibitor-free immunosuppression
RxNorm normalized name: Mammalian target of rapamycin (mTOR) kinase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mTOR-inhibitor-free immunosuppression
Trial: 19641760
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (group 3, 16 individuals, average age 10 years 4 months, no treatment for 10 months)
Trial: 12748432
Drug: Postoperative subfascial
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative subfascial infusion with 0.5% bupivacaine at 2 ml per hour for 48 hours
Trial: 12748432
Drug: Oral analgesics
RxNorm normalized name: ANALGESIC CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral analgesics alone (nonpump group)
Trial: 12748432
Drug: Postoperative subfascial
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative subfascial infusion with 0.5% bupivacaine
Trial: 10654982
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate aqueous nasal spray (MFNS) 100 microg QD
Trial: 9049515
Drug: Total cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total cholesterol levels ≤ 160 mg/dl
Trial: 9049515
Drug: Total cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total cholesterol levels > 160 mg/dl (controls)
Trial: 29656569
Drug: Iron‐folic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron‐folic acid (IFA) capsules
Trial: 29656569
Drug: Multiple micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple micronutrient (MMN) capsules
Trial: 29656569
Drug: All supplements
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All supplements (SQ‐LNS, IFA, MMN)
Trial: 23753114
Drug: GnRHa trigger
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRHa trigger (0.5 mg buserelin) followed by a single bolus of 1.500 IU hCG
Trial: 23753114
Drug: GnRHa trigger
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRHa trigger (0.5 mg buserelin) followed by two boluses of 1.500 IU hCG
Trial: 18707619
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta 30,000 IU once weekly
Trial: 18707619
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta 20,000 IU once weekly
Trial: 18707619
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta (both doses)
Trial: 16651750
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch 20 cm2 (TNP-20x1)
Trial: 16651750
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch 20 cm2 (TNP-20x2)
Trial: 16651750
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch 30 cm2 (TNP-30x1)
Trial: 14672298
Drug: Meat supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meat supplementation (60-85 g/d)
Trial: 14672298
Drug: Milk supplementation
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk supplementation (200-250 mL/d)
Trial: 30285891
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine treatment for IBS (control group)
Trial: 22350285
Drug: Sonophoresis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonophoresis with SonoPrep® followed by EMLA® cream application
Trial: 22350285
Drug: Sham sonophoresis
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham sonophoresis followed by EMLA® cream application
Trial: 14664421
Drug: rHuEPO 600
RxNorm normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO 600 U/kg once weekly for three weeks plus iron supplementation
Trial: 27565651
Drug: Investigational receptor‐specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational receptor‐specific partial agonist drug
Trial: 18928632
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (traditional hormonal therapy and immunosuppressive therapy)
Trial: 16813184
Drug: Difference in
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Difference in VAS after treatment between groups
Trial: 14663473
Drug: Periprostatic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periprostatic injection anesthesia with 10 cm3 (5 cm3 each side) 1% lidocaine
Trial: 11042231
Drug: Tiagabine 2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiagabine 2.5, 5, 7.5 or 10 mg twice daily